Metabolomics, sleepiness, and sleep duration in sleep apnea.

CONCLUSION: Advancing metabolomics research in sleep apnea will guide symptom research and provide alternate and novel opportunities for effective treatment for patients with OSA. PMID: 31955318 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31955318?dopt=Abstract

Source: Sleep and Breathing - January 17, 2020 Category: Sleep Medicine Authors: Diallo I, Pak VM Tags: Sleep Breath Source Type: research